Clal to launch two foreign funds

Clal Finance Mutual Funds will launch two mutual funds Thursday that will make investments abroad.

By YIGAL GRAYEFF
December 27, 2005 08:02

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Clal Finance Mutual Funds will launch two mutual funds Thursday that will make investments abroad. Chul Maslul 20 (E) Batucha will place up to 20% of its funds in foreign shares and options, with the rest to be invested in bonds, including foreign corporate bonds, Clal said on Monday. Batucha Focus Chul will invest the majority of its money in foreign shares or securities that track indexes. Clal said the opening of foreign markets to the domestic market allows retail investors to widen their portfolios and expose themselves to international companies.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS